All systems operational
Q1 2025

Cyclic-imide derivative (5e) attenuates hyperglycemia in type 1 diabetic rats by protecting pancreatic cells and enhancing insulin secretion

Wael A. Alanazi · Ali H. Alenezi · Doaa M. El-Nagar · Mohammed M. Alanazi · Mohammed M. Almutairi · Alaa A.-M. Abdel-Aziz · Adel S. El-Azab
10.1007/s44446-025-00057-9 392 Views 0 Citations
0
Citations
392
Views
Abstract not available for this publication.
Cite this Article (APA)
Wael, A. A., Ali, H. A., Doaa, M. E., Mohammed, M. A., Mohammed, M. A., Alaa, A. A., Adel, S. E. (2025). Cyclic-imide derivative (5e) attenuates hyperglycemia in type 1 diabetic rats by protecting pancreatic cells and enhancing insulin secretion. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-025-00057-9
Related Papers
Human plasma derived exosomes: Impact of active and passive drug loading approaches on drug delivery
Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024
40
cites
395
Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems
Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024
30
cites
390
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities
Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024
26
cites
394
Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …
Faisal Imam; Sayantan Mukhopadhyay; Preeti Kothiyal; Samiyah Alshehri; Khalid Sa · 2024
24
cites
392
Access
View Full Text via DOI
Published in
ISSN 1319-0164
Quartile Q1
AMS Score 100
Field Medicine & Health Sciences
Publisher Elsevier / Saudi Pharmaceutical Soc
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2025
Language English
Added 23 Jul 2026